New Rhein Healthcare Investors is a venture capital firm that provides investment management services, primarily to private investment funds. New Rhein identifies and evaluates investment opportunities, negotiates terms, manages investments, and seeks dispositions. The firm invests in pharmaceutical and medical device companies. New Rhein's advisory board and Executives in Residence assist with identifying investments and due diligence.
Fee Structure
New Rhein Healthcare Investors manages investments for private funds. Investors in these funds generally pay a management fee based on their commitment amount. For 2018 vintage funds, the fee is 1.75% per year of aggregate investment contributions not disposed of or written off, billed semi-annually in advance. For 2021 vintage funds, the fee is 2.00% of an investor's commitment per year, collected quarterly in advance. These fees may be waived or reduced at the discretion of the General Partner. The management fee is generally reduced after the investment period and offset by certain expenses.